Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Int J Diabetes Dev Ctries. 2021 Apr 7;41(4):614–620. doi: 10.1007/s13410-021-00944-6

Table 2.

Univariate and multivariate linear regression analyses for factors associated with QTc interval

Unadjusted linear regression analysis
Adjusted linear regression analysis
Variable β coefficient (95% CI) p value β coefficient (95% CI) p value
Age in years 0.25 (−0.001 to 0.51) 0.050 0.09 (−0.17 to 0.35) 0.491
Female sex 15.52 (10.29–20.61) <0.001 15.26 (7.58–22.94) <0.001
BMI in kg/m2 0.31 (−0.14 to 0.76) 0.182
Waist circumference in cm 0.09 (−0.09 to 027) 0.334
Duration of diabetes in years 0.38 (−0.04 to 0.80) 0.074 0.18 (−0.75 to 0.39) 0.532
Fasting blood sugar in mmol/L −0.06 (−0.57 to 0.46) 0.832
HbA1c (%) −0.07 (−1.04 to 0.89) 0.887
History of hypertension 7.39 (2.02–12.76) 0.007
Resting systolic blood pressure in mmHg 0.18 (0.07–0.29) 0.002
Resting diastolic blood pressure in mmHg 0.41 (0.18–0.64) 0.001
Mean arterial pressure in mmHg 0.34 (0.16–0.53) <0.001 0.34 (0.07–0.63) 0.019
Pulse pressure in mmHg 0.14 (−0.01 to 0.28) 0.057
Antihypertensive drugs
 None Ref Ref
 Diuretic 11.72 (−4.25 to 27.69) 0.149 10.07 (−4.97 to 25.11) 0.187
 ACEI/ARB 11.77 (−0.69 to 24.23) 0.064 10.70 (−1.19 to 22.58) 0.077
 Beta blocker 8.63 (−9.23 to 26.50) 0.341 4.55 (−13.09 to 22.19) 0.611
 Calcium channel blocker 17.34 (4.97–29.72) 0.006 14.65 (−0.67 to 26.57) 0.054

CI confidence interval, BMI body mass index, HbA1c glycosylated hemoglobin, ARB angiotensin receptor blocker, ACEI angiotensin-converting enzyme inhibitor, Ref reference category